BIRGIT ZECH
CEO

With 20 years of experience working in the biotechnology sector in the EU and US, Birgit brings significant competence to Anavo in areas such as Operations, Business Development and Intellectual Property. She played a crucial role in establishing Business Development departments in many of her previous biotech companies including Gotham Therapeutics, which she co-founded, X-Rx, MabDiscovery GmbH, Pieris AG, and started her scientific career at Axxima Pharmaceuticals AG. Birgit has an excellent track record in fund raising and global deal making in major markets with >$1bn in overall accumulated deal value. Birgit obtained her PhD in chemistry at the University of Erlangen-Nuernberg, Germany.